Senate passes bipartisan resolution on prostate cancer

0


September 23, 2021

S. Res. 378 designates September 2021 as Prostate Cancer Awareness Month

Washington DC–U.S. Senators Mike Crapo (R-Idaho) and Bob Menendez (D-New Jersey) hailed the unanimous passage of their bipartisan Senate resolution designating September 2021 as National Prostate Cancer Awareness Month. According to the American Cancer Society, prostate cancer is the most common cancer in American men. More than 3.1 million men live with prostate cancer in the United States, and 1 in 8 men in the country are expected to be diagnosed with the disease in their lifetime. Senate Resolution 378 aims to raise awareness of prostate cancer, promote early detection, and encourage increased federal investments and research to improve treatment and find a cure for the disease. Representative Donald M. Payne, Jr. (D-New Jersey) introduced a complementary resolution in the House of Representatives.

“Early screenings and warnings are important tools when it comes to detecting and treating cancer,” said Senator Crapo. “Prostate cancer checkups and tests can save lives if caught early. Congress must use all avenues available to continue to raise awareness of the risks and early screening to fight prostate cancer. “

“With nearly a quarter of a million men expected to be diagnosed with prostate cancer this year alone, awareness and early detection are key to survival.” Senator Menendez said. “Prostate cancer is the second leading cause of cancer-related death in men in the United States, but when diagnosed early it can be highly treatable. During this month, we are committed to raising awareness and encouraging men of all ages to talk to their doctors and assess their risk, and also to encourage the research and development of better treatments and a potential cure.

“Prostate cancer is the second leading cause of cancer death in American men nationwide, but men can survive if they catch it early.” said Rep. Donald M. Payne, Jr. “As chair of the Congressional Men’s Health Caucus, I presented this resolution to raise awareness of this disease, increase prostate cancer screenings and save lives. I am honored that the Senate has passed our bipartite and bicameral legislation to designate September 2021 as Prostate Cancer Awareness Month. “

“At ZERO – The End of Prostate Cancer, we congratulate Senator Menendez and Senator Crapo for their leadership in prostate cancer policy throughout the year, but especially during Cancer Awareness Month. prostate. Simply put, early detection saves lives. Raising awareness of prostate cancer is a necessary step in helping men and their families fight this disease and we are proud to support our allies in Congress in this task ”, said Jamie Bearse, CEO of ZERO – The End of Prostate Cancer, the nation’s leading prostate cancer advocacy organization.

The American Cancer Society estimates that by 2021, 248,530 men will be diagnosed with prostate cancer, leading to the deaths of more than 34,100 men. African American men suffer from a significantly higher incidence rate of prostate cancer than white men, with more than double the death rate from prostate cancer.

Senators Angus King (I-Maine), Richard Blumenthal (D-Connecticut), Ben Cardin (D-Maryland), Cory Booker (D-New Jersey), Chris Van joined Senators Crapo and Menendez as co- original sponsors of the resolution. Hollen (D-Maryland), James Risch (R-Idaho), Alex Padilla (D-California), Ed Markey (D-Massachusetts), Chris Coons (D-Delaware), Ron Wyden (D-Oregon) and Shelley Moore Capito (R-West Virginia).

The full text of the resolution can be found below and HERE.

Title: Designate September 2021 as “National Prostate Cancer Awareness Month”.

Whereas over 3,100,000 men in the United States are living with prostate cancer;

Whereas one in 8 men in the United States will be diagnosed with prostate cancer in their lifetime and one in 41 men in the United States will die of prostate cancer;

Whereas prostate cancer is the most commonly diagnosed non-skin cancer and the second leading cause of cancer-related death in men in the United States;

Whereas the American Cancer Society estimates that in 2021, 248,530 men will be diagnosed and over 34,130 men will die of prostate cancer;

Whereas 40 percent of newly diagnosed prostate cancer cases occur in men under the age of 65;

Whereas the chances of developing prostate cancer increase rapidly after the age of 50;

Whereas African American men suffer from a significantly higher incidence rate of prostate cancer than that of white men and have more than double the death rate from prostate cancer than that of white men;

Whereas having a father or sibling with prostate cancer more than doubles the risk of a man developing prostate cancer, with a higher risk for men who have an affected sibling of the disease and the highest risk for men with more than one affected parent;

Whereas screening by digital rectal examination and blood test for prostate specific antigen can detect the disease at earlier and more treatable stages, which could increase the chances of survival for more than 5 years to almost 100%;

Whereas only 30 percent of men survive more than 5 years if they are diagnosed with prostate cancer after the cancer has metastasized;

Whereas there are generally no visible symptoms of prostate cancer in the early stages, which makes proper screening essential;

Whereas, in fiscal 2021, the Director of the National Institutes of Health will support approximately $ 256,000,000 in research projects focused specifically on prostate cancer;

Whereas, in fiscal year 2021, Congress allocated $ 110,000,000 to the Department of Defense Prostate Cancer Research Program;

Whereas the Department of Veterans Affairs has established 20 Precision Oncology Centers of Excellence to provide precision oncology services to veterans with prostate cancer;

Whereas current research promises further improvements in the prevention, early detection and treatment of prostate cancer; and

Whereas educating people in the United States, including healthcare providers, about prostate cancer and early detection strategies is crucial to saving men’s lives and preserving and protecting families:

Resolved, That the Senate—

(1) designate September 2021 as “National Prostate Cancer Awareness Month”;

(2) states that action must be taken—

(A) raise awareness of the importance of prostate cancer screening and treatment methods;

(B) to encourage research—

(i) improve the detection and treatment of prostate cancer;

(ii) discover the causes of prostate cancer; and

(iii) develop a cure for prostate cancer; and

(C) continue to consider ways to improve access to and quality of health care services for prostate cancer screening and treatment; and

(3) calls on the people of the United States, interest groups and those affected—

(A) to promote prostate cancer awareness;

(B) play an active role in the fight to end the devastating effects of prostate cancer on individuals, families and the economy; and

(C) observe National Prostate Cancer Awareness Month with appropriate ceremonies and activities.

###


Leave A Reply

Your email address will not be published.